Hong Jun Liang
Direttore/Membro del Consiglio presso BEIJING STRONG BIOTECHNOLOGIES,INC.
Posizioni attive di Hong Jun Liang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Direttore/Membro del Consiglio | 13/08/2020 | - |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Direttore/Membro del Consiglio | 15/09/2020 | - |
Storia della carriera di Hong Jun Liang
Precedenti posizioni note di Hong Jun Liang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| JIANGSU HENGRUI MEDICINE CO., LTD. | Direttore/Membro del Consiglio | 13/11/2018 | 01/01/2020 |
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Presidente | - | 15/11/2019 |
Statistiche
Distribuzione geografica
| Cina | 5 |
Posizioni
| Director/Board Member | 3 |
| Chairman | 1 |
Settori
| Health Technology | 4 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
| JIANGSU HENGRUI MEDICINE CO., LTD. | Health Technology |
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
- Borsa valori
- Insiders
- Hong Jun Liang
- Esperienza
